APVO 8-K 2026-11-02

Aptevo Therapeutics Inc. (APVO) 8-K dated 2026-11-02 — accession 0001193125-26-442031.

Aptevo Therapeutics Inc. (APVO) is a biotechnology company listed on US.

Aptevo Therapeutics Inc. filed a 8-K on 2026-11-02. Accession 0001193125-26-442031.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported APVO revenue for 2022-12-31 was $3.1M. Net income was $8.0M. APVO currently screens at market cap $9.9M.

Not investment advice. The APVO SEC hub lists recent forms. The stock page is the research view.